Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Spin-Off Company Developing New Antibiotics

MRSA bacteria

A start-up enterprise in the U.K. is commercializing research from a university lab that discovered a new class of antibiotics promising to treat drug-resistant bacterial infections. . . . → Read More: Spin-Off Company Developing New Antibiotics

Exosuit Designed for Personalized Walking Help

Military exosuit

A wearable robotic exoskeleton designed into textiles to provide personalized assistance is shown in lab and field tests to reduce the amount effort needed to walk long distances. . . . → Read More: Exosuit Designed for Personalized Walking Help

Gilead Gains Genome-Editing Hepatitis B Therapy

Hepatitis-B virus

Biopharmaceutical company Gilead Sciences is acquiring a genome-editing technology for treating hepatitis-B, a viral disease affecting the liver. . . . → Read More: Gilead Gains Genome-Editing Hepatitis B Therapy

Personalized Breast Cancer Trial Advances 7 Drugs

Laura Esserman

A clinical trial with a design that allows for changes in its processes to meet the needs of individual patients says its results helped advance 7 new drugs for breast cancer into review by FDA. . . . → Read More: Personalized Breast Cancer Trial Advances 7 Drugs

A.I. to Identify Treatment Drivers for Colorectal Cancer

Data and person graphic

A study will soon get underway with artificial intelligence and simulation analyzing data from clinical trials to identify factors behind responses to a treatment for colorectal cancer. . . . → Read More: A.I. to Identify Treatment Drivers for Colorectal Cancer

Genomics-Blockchain Company Launches, Raises $4.3 Million

Blockchain network graphic

A new enterprise that promises to collect and protect a person’s genomic data with blockchain technology is starting up with the help of a genomics legend and $4.3 million in seed financing. . . . → Read More: Genomics-Blockchain Company Launches, Raises $4.3 Million

Genentech Gains Modular Engineered Antibodies in $5B Deal

Natural killer cell

A developer of synthetic antibodies that invoke the immune system is partnering with the biopharmaceutical company Genentech to design new therapies for blood-related and solid tumor cancers. . . . → Read More: Genentech Gains Modular Engineered Antibodies in $5B Deal

UPDATE: 23andMe Shuts Down Open API Access to Raw Data

DNA analysis graphic

The personal genetics company 23andMe is closing down access to its raw genomic data for independent software developers. . . . → Read More: UPDATE: 23andMe Shuts Down Open API Access to Raw Data

Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies

Mountain bluebird

Two biotechnology enterprises developing cancer treatments are pooling their efforts to develop therapies aimed at more specific targets across a range of solid tumor types. . . . → Read More: Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies

Bread Wheat Genome Sequenced

Growing wheat

An international collaboration published a complete, annotated genomic sequencing of wheat used in making bread, a widely grown staple crop and major source of nutrition worldwide. . . . → Read More: Bread Wheat Genome Sequenced